Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
2012 to 2015 saw rise in US insulin prices
Jun 16, 2023
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.
AHA: Fresh produce prescription improves glycemic control
Nov 14, 2023
The findings were seen among low-income individuals with diabetes and poor glycemic control.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Eli Lilly to slash insulin prices, cap monthly out-of-pocket costs at $35
Mar 01, 2023
The company will cut its list price for Humalog 100 units/mL starting in the fourth quarter of 2023.
59.5 percent of adult ED visits are for patients with chronic conditions
Sep 02, 2022
Among adults with three or more chronic conditions, Medicare was the most frequently observed expected source of payment.
How will new federal legislation cut drug costs?
Aug 12, 2022
Under the law, Medicare will now be allowed to negotiate the cost of some drugs, and vaccines will be free for Part D recipients.
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.